|
| |
Duke Clinical Research InstituteThe Duke Clinical Research Institute (DCRI) has always been ahead of its time. We are an academic research organization that for more than 17 years has combined the best of the academic environment with a customer-driven focus, to perform world-class clinical research and outcomes analysis for our clients. Our 750+ employees are dedicated to providing the best services, with the ultimate goal of improving the care and outcomes of patients around the world. Whether assisting with a small, focused study or coordinating a large, multinational clinical trial, we bring the same enthusiasm and professionalism to all of our projects. While the DCRI's foundation is anchored in the conduct of international cardiology trials, the DCRI's expertise and offerings go well beyond cardiology to include CNS, Infectious Diseases and other key therapeutic areas.
| Contact Details: |
| P.O. Box 17969 |
| Durham |
| NC |
| 27715 |
| United States of America |
| Tel: | 919-668-8700 |
| Fax: | 919-668-7000 |
| Email: | dcriweb@onyx.dcri.duke.edu. |
| WWW: | www.dcri.duke.edu/
|
|
Loading...
|
Recent Publications by Duke Clinical Research Institute: |  |
Interpreting the TRITON Results in Light of the Event Adjudication Process.
According to activation-based models of spoken-word recognition, words... | 13th November, 2009
| Duke University Medical Center, Duke Clinical Research Institute, Durham,
| Cardiology. 2009 Nov 7;115(2):89-90.
DOI Direct Link |
An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents.
AIM: This study applied both item response theory (IRT) and multiple... | 10th November, 2009
| Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke
| Addict Behav. 2009 Oct 22.
DOI Direct Link |
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
The effect of nonstandardized creatine kinase (CK)-MB assays on the... | 7th November, 2009
| Duke Clinical Research Institute, Durham, North Carolina, USA.
| Am J Cardiol. 2009 Nov 15;104(10):1330-5. Epub 2009 Sep 25.
DOI Direct Link |
Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome.
We evaluated the reported contraindications to early beta-blocker use and... | 7th November, 2009
| Duke Clinical Research Institute, Durham, North Carolina, USA.
| Am J Cardiol. 2009 Nov 15;104(10):1324-9. Epub 2009 Sep 26.
DOI Direct Link |
A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.
The CHOIR trial in anemic patients with chronic kidney disease compared... | 6th November, 2009
| [1] Renal Division, Department of Medicine, Duke University Medical
| Kidney Int. 2009 Nov 4.
DOI Direct Link |
→View more Duke Clinical Research Institute research publications. |
Press Releases on Duke Clinical Research Institute:
|
 |
| American Heart Association Late-Breaking Clinical Trial Report: New Reversible Antiplatelet Drug no More Effective Than Irreversible One in PCI |
15th November, 2009 |
American Heart Association |
Study highlights:
- A new reversible, intravenous blood thinner did not show superiority over an irreversible one currently approved for use.
- Further investigation of the new anti-clotting drug is
|
| Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial |
13th August, 2009 |
Abbott |
ABBOTT PARK, Ill., Aug. 13 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the expansion of the company's XIENCE V(R) USA post-approval study designed to evaluate the safety and
|
| HITSP Begins Harmonization Process for Use of Electronic Health Records in Clinical Research |
15th June, 2009 |
American National Standards Institute |
Thirty-five leading organizations from the clinical research community have pledged support for new initiative
WASHINGTON, June 15 /PRNewswire-USNewswire/ -- The Healthcare Information Technology
|
| Regado Biosciences Establishes Medical Advisory Board |
2nd June, 2009 |
Regado Biosciences, Inc. |
BASKING RIDGE, N.J., June 2 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today
|
| Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery |
11th May, 2009 |
Schering-Plough Corporation |
RED-CABG Trial Initiates Patient Recruitment for Potentially Life-Saving Agent
KENILWORTH, N.J., May 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced the start of
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 177 individuals from Duke Clinical Research Institute using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 591 times since April 2007, the link to the organisation's website has been followed 109 times Recent Search Terms used to find this page: duke clinical study | Duke and Schering Plough | duke drug discovery institute | duke clinical research institute logo | duke drug | Schering-Plough DUKE clinical research institute | Duke Drug Discovery | duke drug discovery institute map | duke research institute | duke drug discovery institute | . Search for more companies in Durham Search for more companies in NC This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Duke Clinical Research Institute |
